12-Month Lobbying Summary - Consultant Lobbyist

Canadian Generic Pharmaceutical Association (CGPA) / Dean Crawford, Consultant Lobbyist

Registration Summary

Currently active - Last Updated: 2024-12-13

Who is lobbying?

Canadian Generic Pharmaceutical Association (CGPA) (Address & business activities)

Government Funding

Did Canadian Generic Pharmaceutical Association (CGPA) request or receive government funding within the last 12 months? No

Coalition Members Information

Canadian Generic Pharmaceutical Association (CGPA) is not a coalition member.

Direct Interests of the Lobbying Activity

Affiliates

Canadian Generic Pharmaceutical Association (CGPA) does not have any affiliates that could have a direct interest in the outcome of the lobbying activities

Other Affiliates

The activities of Canadian Generic Pharmaceutical Association (CGPA) are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Canadian Generic Pharmaceutical Association (CGPA):

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will the consultant lobbyist be arranging meetings between a public office holder and the client for the purpose of attempting to influence any of the matters listed:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Arranging a meeting between the CGPA and Ministerial Staff to provide a briefing on generic and biosimilars sectors and pan-Canadian Pharmaceutical Alliance agreement.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Continued support for Ministry of Health's policies regarding switching patients to biosimilar medicines from biologics	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Encouraging Support for the CGPA Blueprint for Sustainable Supply of Prescription Medicines for Canadians	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Expansion of reimbursement criteria by the Government of British Columbia for biosimilar products.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Invitation to Minister of Health to attend meeting with members of the CGPA, either at the annual members' meeting or at another time.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Policy and timing in respect of listing of sole-source and other generic drugs on the PharmaCare formulary where the price offered is higher than the Province's desired price. BC's position in respect of administration of pan-Canadian Pharmaceutical Association arrangements with the CGPA regarding generic drugs. Curtailing use of coupon cards for pharmaceutical products. Development of a regulatory pathway for biosimiars. Implementation of commitments made by British Columbia pursuant to its involvement with the pan-Canadian Pharmaceutical Alliance. Promoting greater utilization of generic prescription medicines. BC's position in respect of the National Pharmacare initiative. Accelerating time for listing of generic drugs after submission.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Requesting Pharmaceutical, Laboratory & Blood Services Division to provide firm written notice of price changes for reimbursement of generic drugs and listing of new generic drugs and earlier publication of changes to on-line formulary.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Signing Authority for Ministerial Orders to list generic products on the PharmaCare formulary	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Support for pan-Canadian Pharmaceutical Alliance agreement with Canadian Generic Pharmaceutical Association and for early negotiation of a renewal agreement.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health

Gifts or Benefits Provided to Public Officer Holders

Lobbyists are required to provide information regarding gifts or benefits provided within the last 12 months to a public office holder they have lobbied. For more information, review the Guide to Lobbyist Gifts.

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Health
Member(s) of the BC Legislative Assembly
Office of the Premier

Who is the lobbyist?

Dean Crawford, Consultant Lobbyist (Business address and contact information)

Pulver Crawford Munroe LLP (Address & contact information)

Former Public Office Holder in BC: No

Relevant Codes of Conduct: Yes, the consultant lobbyist does have in place an undertaking to comply with a relevant code of conduct

Individuals Hired by the Consultant Lobbyist to Lobby on Behalf of the Client:

No individuals have been hired or subcontracted to lobby on behalf of the client for this registration.

Contingency Information:

Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the outcome of this lobbying activity.
Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the success in arranging a meeting with public office holders on behalf of the client.

Who has provided contributions?

Consultant has lobbied, or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this client, on or after 2024-09-21:

Yes

Has made a political contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No
Has made a sponsorship contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No
Has made a recall contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No

Registration number: 1228-751
View all registrations versions

Lobbying Activity Reports

What lobbying activities have taken place in the last 12 months?

What lobbying activities have taken place in the last 12 months?
Date	Arranging a Meeting	Senior Public Office Holder, Position Title \| Ministry/Provincial Entity	Subject Matters
2024-11-21	No	Mitch Moneo, Assistant Deputy Minister \| Pharmaceutical, Laboratory & Blood Services Division, Health	View
2024-01-10	No	Mitch Moneo, Assistant Deputy Minister \| Pharmaceutical, Laboratory & Blood Services Division, Health	View

View all Lobbying Activity Reports

Date Modified:: 2024-12-13

Menus

www.lobbyistsregistrar.bc.ca

12-Month Lobbying Summary - Consultant Lobbyist

Canadian Generic Pharmaceutical Association (CGPA) / Dean Crawford, Consultant Lobbyist

Who is lobbying?

Canadian Generic Pharmaceutical Association (CGPA) (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

What is being lobbied?

Details Regarding the Identified Subject Matter

Gifts or Benefits Provided to Public Officer Holders

Who is being lobbied?

Ministries/Provincial Entities

Who is the lobbyist?

Dean Crawford, Consultant Lobbyist (Business address and contact information)

Who has provided contributions?

What lobbying activities have taken place in the last 12 months?

12-Month Lobbying Summary - Consultant Lobbyist

Canadian Generic Pharmaceutical Association (CGPA) / Dean Crawford, Consultant Lobbyist

Canadian Generic Pharmaceutical Association (CGPA) (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

Details Regarding the Identified Subject Matter

Gifts or Benefits Provided to Public Officer Holders

Ministries/Provincial Entities

Dean Crawford, Consultant Lobbyist (Business address and contact information)

Canadian Generic Pharmaceutical Association (CGPA) - Address & business activities

Canadian Generic Pharmaceutical Association (CGPA) / Dean Crawford, Consultant Lobbyist

Pulver Crawford Munroe LLP